Skip to main content
Rany Aburashed, DO, Neurology, Chicago, IL, Memorial Healthcare

RanyAAburashedDO

Neurology Chicago, IL

Neuroimmunology/Multiple Sclerosis

Corporate chief medical officer, Insight corporation. Corporate chief of specialty services. Chairman department of neurosciences. Insight Chicago hospital and medical center. Insight Iowa, Insight surgical Hospital Warren MI

Dr. Aburashed is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Aburashed's full profile

Already have an account?

  • Office

    Insight Hospital & Medical Center
    2525 S Michigan Ave
    Chicago, IL 60616
    Phone+1 989-723-1390
    Fax+1 989-725-1415
  • Is this information wrong?

Education & Training

  • Sparrow Hospital/Michigan State University
    Sparrow Hospital/Michigan State UniversityResidency, Neurology, 2007 - 2010
  • Michigan State University College of Osteopathic Medicine
    Michigan State University College of Osteopathic MedicineClass of 2006

Certifications & Licensure

  • IL State Medical License
    IL State License 2023 - 2026
  • MI State Medical License
    MI State License 2006 - 2026
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013

Publications & Presentations

PubMed

Press Mentions

  • The Problem with Aducanumab: Approved for Alzheimer's
    The Problem with Aducanumab: Approved for Alzheimer'sAugust 25th, 2021
  • 'This Is Not a Shotgun Approach to Dementia': Hospital Execs Share How They're Rolling Out Aduhelm
    'This Is Not a Shotgun Approach to Dementia': Hospital Execs Share How They're Rolling Out AduhelmJune 17th, 2021
  • New Alzheimer’s Drug Aducanumab: Cost, Side Effects, Timeline and Other Questions Answered
    New Alzheimer’s Drug Aducanumab: Cost, Side Effects, Timeline and Other Questions AnsweredJune 10th, 2021
  • Join now to see all

Hospital Affiliations